CD226 opposes TIGIT to disrupt Tregs in melanoma-Reference-Cited by-同舟云学术

CD226 opposes TIGIT to disrupt Tregs in melanoma

Published:2018-07-25 Issue:14 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Fourcade Julien,Sun Zhaojun,Chauvin Joe-Marc^ORCID,Ka Mignane,Davar Diwakar^ORCID,Pagliano Ornella^ORCID,Wang Hong,Saada Sofiane,Menna Carmine,Amin Rada,Sander Cindy^ORCID,Kirkwood John M.,Korman Alan J.,Zarour Hassane M.

Funder

U.S. Department of Defense

NIH/NCI

Cancer Research Institute

Bristol-Myers Squibb

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/121157/files/pdf

Reference43 articles.

1. Regulatory T Cells and Immune Tolerance

2. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

3. FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma

4. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases

5. Selective accumulation of differentiated FOXP3+ CD4+ T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?;Critical Reviews in Oncology/Hematology;2024-09

2. Targeting the dynamic transcriptional landscape of Treg subpopulations in pancreatic ductal adenocarcinoma: Insights from single-cell RNA sequencing analysis with a focus on CTLA4 and TIGIT;Immunobiology;2024-07

3. Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?;Cells;2024-06-01

4. Treg fitness as a biomarker for disease activity in Juvenile Idiopathic Arthritis;2024-04-28

5. CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy;Current Medicinal Chemistry;2024-04